21 May 2025
Analysis, Immunicum: New capital for expansion
27 Nov 2017
With promising clinical results, Immunicum plans to expand the clinical strategy for its cancer therapy ilixadencel. A proposed share issue will provide capital to reach important clinical value inflection points.
Read the full report here.